Endowment Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Endowment Wealth Management's ABBV Position: Q2 2026 in Review
Endowment Wealth Management increased its AbbVie (ABBV) stake by 5.6% in Q2 2026, buying an estimated $40K and bringing the position to 3,494 shares worth $879K. The position accounts for 0.34% of the portfolio, ranked #58.
Endowment Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Endowment Wealth Management held 3,494 shares of AbbVie worth $879K as of Q2 2026.
- Endowment Wealth Management bought 186 AbbVie shares in Q2 2026, an estimated $40K.
- AbbVie made up 0.34% of Endowment Wealth Management's portfolio in Q2 2026, its #58 holding.
- Endowment Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Endowment Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.